[Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus]
- PMID: 17237630
[Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus]
Abstract
Background/aim: The liver plays important roles in the homeostasis of glucose metabolism since it acts as a major target organ for insulin and a site for gluconeogenesis and glycogen storage. Diabetes mellitus (DM) commonly develops in patients with liver cirrhosis as the result of hepatocyte dysfunction and/or inadequate mass. To assess differences between DM due to liver cirrhosis (hepatogenous DM) and the other type 2 DM, we compared the patterns of hyperglycemia and hyperinsulinemia in hepatogenous DM with those observed in type 2 DM.
Methods: 18 diabetic patients with liver cirrhosis (caused by alcohol, n=8; HBV, n=5; HCV, n=2; others, n=3) were matched with 18 type 2 diabetic patients without liver cirrhosis for age and gender. None of the patients or controls had been treated with insulin or beta-blockers. The level of glycosylated hemoglobin (HbA1C), fasting plasma glucose (FPG), postprandial plasma glucose (PP2h), fasting plasma C-peptide and insulin were measured.
Results: The ratio of PP2h/FPG (2.27 vs. 1.69), fasting insulin (23.2: 11.6 microIU/mL) and HOMA-IR index (8.38 vs. 3.52) were significantly higher in hepatogenous DM than the other type 2 DM (P<0.05). PP2h, fasting C-peptide and ratio of fasting insulin/C-peptide tend to be higher in hepatogenous DM than those of controls, but which were not statistically significant.
Conclusions: The ratio of PP2h/FPG and fasting plasma insulin differentiated hepatogenous DM from the other type 2 DM. Insulin resistance in liver cirrhosis was higher than the other type 2 DM, and impaired hepatic insulin degradation might be an important mechanism of hyperinsulinemia in liver cirrhosis.
Similar articles
-
Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.J Diabetes Complications. 2007 Mar-Apr;21(2):84-92. doi: 10.1016/j.jdiacomp.2005.11.006. J Diabetes Complications. 2007. PMID: 17331856
-
Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus.Diabet Med. 2005 Nov;22(11):1530-5. doi: 10.1111/j.1464-5491.2005.01687.x. Diabet Med. 2005. PMID: 16241918
-
Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.Diabetes Obes Metab. 2005 Sep;7(5):525-35. doi: 10.1111/j.1463-1326.2004.00424.x. Diabetes Obes Metab. 2005. PMID: 16050945
-
[Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis].Z Gastroenterol. 1999 Jun;Suppl 1:15-21. Z Gastroenterol. 1999. PMID: 10444811 Review. German.
-
[Hepatogenous diabetes - diagnostics and treatment].Z Gastroenterol. 2009 May;47(5):436-45. doi: 10.1055/s-0028-1109200. Epub 2009 May 5. Z Gastroenterol. 2009. PMID: 19418413 Review. German.
Cited by
-
Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?World J Gastroenterol. 2016 Mar 14;22(10):2869-74. doi: 10.3748/wjg.v22.i10.2869. World J Gastroenterol. 2016. PMID: 26973383 Free PMC article.
-
Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?J Clin Diagn Res. 2017 Sep;11(9):OC01-OC05. doi: 10.7860/JCDR/2017/30705.10529. Epub 2017 Sep 1. J Clin Diagn Res. 2017. PMID: 29207749 Free PMC article.
-
Hepatogenous Diabetes as Compared to Type-2 Diabetes Mellitus and Non-diabetes in Patients With Liver Cirrhosis: Magnitude, Characteristics, and Implications.J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101411. doi: 10.1016/j.jceh.2024.101411. Epub 2024 Apr 9. J Clin Exp Hepatol. 2024. PMID: 38699514
-
Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.World J Gastroenterol. 2009 Jan 21;15(3):280-8. doi: 10.3748/wjg.15.280. World J Gastroenterol. 2009. PMID: 19140227 Free PMC article. Review.
-
Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Int J Mol Sci. 2014 May 14;15(5):8591-638. doi: 10.3390/ijms15058591. Int J Mol Sci. 2014. PMID: 24830559 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical